Sanofi’s Lunsekimig Achieves Phase 2 Endpoints in Asthma, CRSwNP Studies
Sanofi's novel bispecific Nanobody VHH, lunsekimig, met primary and key secondary endpoints in its Phase 2 trials for asthma and CRSwNP, the...
Sanofi's novel bispecific Nanobody VHH, lunsekimig, met primary and key secondary endpoints in its Phase 2 trials for asthma and CRSwNP, the...
FMC Corp. secured European Union regulatory approval for its bixlozone herbicide active ingredient, marketed as Isoflex active, marking a critical commercialization milestone....
Soybean futures opened Monday with notable gains of 3 to 5 ½ cents across contracts, signaling a rebound after previous week's mixed...
Imperial Oil (IMO), a Canadian integrated energy company, has achieved 5-year highs and a Zacks Rank #1 (Strong Buy) rating, driven by...
OpenAI is facing an internal debate over its IPO timing, with CFO Sarah Friar reportedly indicating the company may not be ready...
Neurocrine Biosciences is in advanced talks to acquire Soleno Therapeutics for over $2.5 billion, potentially valuing Soleno shares in the low-to-mid $50s,...
Coffee prices, including arabica and robusta futures, fell on Thursday, driven by a stronger U.S. dollar and increasingly optimistic forecasts for Brazil's...
Cotton futures showed mixed performance on Thursday, fluctuating between gains and losses, influenced by strong export sales, a rising US dollar, and...
Cattle futures extended higher on Thursday, with live and feeder contracts posting gains. This rally occurred despite stalled cash trade and declining...